Mechanisms of transport of nucleosides and nucleoside analogues in choroid plexus

Advanced Drug Delivery Reviews

Volumn 39, Issue 1-3, 1999, Pages 51-62

  Schaner, Marci E ^a   Gerstin, Karin M ^a   Wang, Juan ^a   Giacomini, Kathleen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

2',3' Dideoxycytidine; 2',3' Dideoxyinosine; Azidothymidine; Blood brain barrier; Central nervous system; Nucleobase; Nucleoside analogue; Nucleoside transporter

Indexed keywords

BLOOD; BRAIN; NEUROLOGY;

BLOOD-BRAIN BARRIER; NUCLEOSIDES;

CONTROLLED DRUG DELIVERY;

CARRIER PROTEIN; CYTARABINE; DIDANOSINE; FORMYCIN B; NUCLEIC ACID BASE; NUCLEOSIDE; NUCLEOSIDE ANALOG; ZALCITABINE; ZIDOVUDINE;

AIDS RELATED COMPLEX; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM INFECTION; CHOROID PLEXUS; CYTOMEGALOVIRUS INFECTION; DEMENTIA; HERPES SIMPLEX ENCEPHALITIS; HISTOCHEMISTRY; HUMAN; INULIN CLEARANCE; MAMMAL CELL; MONKEY; NONHUMAN; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; RABBIT; RAT; RETINITIS; REVIEW; SHEEP; SPECIES DIFFERENCE;

EID: 0032870880     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(99)00019-8     Document Type: Article

References (76)

1. Spector R., Johanson C.E. The mammalian choroid plexus. Sci. Am. 261:1989;68-74.
2. Johanson C.E. Neuwalt E.A. Implications of the Blood-Brain Barrier and Its Manipulation. Potential For Pharmacologic Manipulation of the Blood-Cerebrospinal Fluid Barrier. 1:1989;223-260 Plenum, New York.
3. Cornford E.M., Oldendorf W.H. Independent blood-brain barrier transport systems for nucleic acid precursors. Biochim. Biophys. Acta. 394:1975;211-219.
4. Wu X., Gutierrez M.M., Giacomini K.M. Further characterization of the sodium-dependent nucleoside transporter (N3) in choroid plexus from rabbit. Biochim. Biophys. Acta. 1191:1994;190-196.
5. Wu X., Yuan G., Brett C.M., Hui A.C., Giacomini K.M. Sodium-dependent nucleoside transport in choroid plexus from rabbit. Evidence for a single transporter for purine and pyrimidine nucleosides. J. Biol. Chem. 267:1992;8813-8818.
6. Betz A.L. Identification of hypoxanthine transport and xanthine oxidase activity in brain capillaries. J. Neurochem. 44:1985;574-579.
7. Cardelli P., Fiori A., Santulli M.C., Ceci F., Salerno C., Savi M.R., Peresempio V., Strom R. Effect of inorganic phosphate on hypoxanthine transport in isolated brain microvessels. Biochem. Int. 28:1992;823-834.
8. Nakagawa S., Guroff G. The uptake of purines by rat brain in vivo and in vitro. J. Neurochem. 20:1973;1141-1149.
9. Hogans A.F., Guroff G., Udenfriend S. Studies on the origin of pyrimidines for biosynthesis of neural RNA in the rat. J. Neurochem. 18:1971;1699-1710.
10. Fletcher C.V., Balfour H.H. Jr. Evaluation of ganciclovir for cytomegalovirus disease. DICP. 23:1989;5-12.
11. Fletcher C., Sawchuk R., Chinnock B., deMiranda P., Balfour H.H. Jr. Human pharmacokinetics of the antiviral drug DHPG. Clin. Pharmacol. Ther. 40:1986;281-286.
12. Booss J., Kim J.H. Cytomegalovirus encephalitis: neuropathological comparison of the guinea pig model with the opportunistic infection in AIDS. Yale J. Biol. Med. 62:1989;187-195.
13. Cheesbrough J.S., Finch R.G., Ward M.J. A case of herpes zoster associated encephalitis with rapid response to acyclovir. Postgrad. Med. J. 61:1985;145-146.
14. Davenport A., Goel S., Mackenzie J.C. Neurotoxicity of acyclovir in patients with end-stage renal failure treated with continuous ambulatory peritoneal dialysis. Am. J. Kidney Dis. 20:1992;647-649.
15. deMiranda P., Krasny H.C., Page D.A., Elion G.B. Species differences in the disposition of acyclovir. Am. J. Med. 73:1982;31-35.
16. deMiranda P., Blum M.R. Pharmacokinetics of acyclovir after intravenous and oral administration. J. Antimicrob. Chemother. 12:1983;29-37.
17. Tyms A.S., Taylor D.L., Parkin J.M. Cytomegalovirus and the acquired immunodeficiency syndrome. J. Antimicrob. Chemother. 23:1989;89-105.
18. Sawchuk R.J., Hedaya M.A. Modeling the enhanced uptake of zidovudine (AZT) into cerebrospinal fluid. 1. Effect of probenecid. Pharm. Res. 7:1990;332-338.
19. Haefeli W.E., Schoenenberger R.A., Weiss P., Ritz R.F. Acyclovir-induced neurotoxicity: concentration-side effect relationship in acyclovir overdose. Am. J. Med. 94:1993;212-215.
20. Klecker R.W. Jr., Collins J.M., Yarchoan R., Thomas R., Jenkins J.F., Broder S., Myers C.E. Plasma and cerebrospinal fluid pharmacokinetics of 3′-azido-3′-deoxythymidine: a novel pyrimidine analogue with potential application for the treatment of patients with AIDS and related diseases. Clin. Pharmacol. Ther. 41:1987;407-412.
21. Cserr H.F. Physiology of the choroid plexus. Physiol. Rev. 51:1971;273-311.
22. Wright E.M., Saito Y. The choroid plexus as a route from blood to brain. Ann. New York Acad. Sci. 481:1986;214-220.
23. Wright E.M. Transport processes in the formation of the cerebrospinal fluid. Rev. Physiol. Biochem. Pharmacol. 83:1978;3-34.
24. Abe T., Kakyo M., Sakagami H., Tokui T., Nishio T., Tanemoto M., Nomura H., Hebert S.C., Matsuno S., Kondo H., Yawo H. Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2. J. Biol. Chem. 273:1998;22395-22401.
25. Angeletti R.H., Novikoff P.M., Juvvadi S.R., Fritschy J.M., Meier P.J., Wolkoff A.W. The choroid plexus epithelium is the site of the organic anion transport protein in the brain. Proc. Natl. Acad. Sci. USA. 94:1997;283-286.
26. +/MYO-inositol co-transporter mRNA in the rat brain. Neuroreport. 7:1996;1195-1198.
27. Dreier R., Schmid K.W., Gerke V., Riehemann K. Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study. Histochem. Cell Biol. 110:1998;137-148.
28. Rogers K.R., Griffin M., Brophy P.J. The secretory epithelial cells of the choroid plexus employ a novel kinesin-related protein. Brain Res. Mol. Brain Res. 51:1997;161-169.
29. Yao S.Y., Ng A.M., Muzyka W.R., Griffiths M., Cass C.E., Baldwin S.A., Young J.D. Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. J. Biol. Chem. 272:1997;28423-28430.
30. Griffiths M., Yao S.Y., Abidi F., Phillips S.E., Cass C.E., Young J.D., Baldwin S.A. Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem. J. 328:1997;739-743.
31. Griffiths M., Beaumont N., Yao S.Y., Sundaram M., Boumah C.E., Davies A., Kwong F.Y., Coe I., Cass C.E., Young J.D., Baldwin S.A. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat. Med. 3:1997;89-93.
32. Crawford C.R., Patel D.H., Naeve C., Belt J.A. Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line. J. Biol. Chem. 273:1998;5288-5293.
33. Sundaram M., Yao S.Y., Ng A.M., Griffiths M., Cass C.E., Baldwin S.A., Young J.D. Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs. J. Biol. Chem. 273:1998;21519-21525.
34. +-dependent, concentrative nucleoside transport in rat macrophages. Specificity for natural nucleosides and nucleoside analogues, including dideoxynucleosides, and comparison of nucleoside transport in rat, mouse, and human macrophages. Biochem. Pharmacol. 42:1991;247-252.
35. +-dependent, active nucleoside transport in S49 mouse lymphoma cells and loss in AE-1 mutant deficient in facilitated nucleose transport. J. Cell. Biochem. 46:1991;54-59.
36. Crawford C.R., Belt J.A. Sodium-dependent concentrative nucleoside transport in Walker 256 rat carcinosarcoma cells. Biochem. Biophys. Res. Commun. 175:1991;846-851.
37. Crawford C.R., Ng C.Y., Noel L.D., Belt J.A. Nucleoside transport in L1210 murine leukemia cells. Evidence for three transporters. J. Biol. Chem. 265:1990;9732-9736.
38. Belt J.A., Marina N.M., Phelps D.A., Crawford C.R. Nucleoside transport in normal and neoplastic cells. Adv. Enzyme Regul. 33:1993;235-252.
39. +-dependent nucleoside transport systems in isolated oocytes of Xenopus laevis. Demonstration that rat jejunum expresses the purine-selective system N1 (cif) and a second novel system N3 having broad specificity for purine and pyrimidine nucleosides. J. Biol. Chem. 268:(cif):1993;20613-20619.
40. Gutierrez M.M., Ott R.J., Hui A.C., Giacomini K.M. Nucleoside transport in brush border membrane vesicles from human kidney. Biochim. Biophys. Acta. 1105:1992;1-9.
41. +-nucleoside transport in brush border membrane vesicles from human kidney. Biochim. Biophys. Acta. 1191:1993;202-208.
42. C.E. Cass, Nucleoside Transport. Drug Transport in Antimicrobial and Anticancer Chemotherapy, N.H. Georgopapadakou (Ed.), Marcel Dekker New York, 1995, pp. 403-451.
43. Griffith D.A., Jarvis S.M. Nucleoside and nucleobase transport systems of mammalian cells. Biochim. Biophys. Acta. 1286:1996;153-181.
44. Yao S.Y., Ng A.M., Ritzel M.W., Gati W.P., Cass C.E., Young J.D. Transport of adenosine by recombinant purine- and pyrimidine-selective sodium/nucleoside cotransporters from rat jejunum expressed in Xenopus laevis oocytes. Mol. Pharmacol. 50:1996;1529-1535.
45. +-dependent purine nucleoside transporter from human kidney: cloning and functional characterization. Am. J. Physiol. 273:1997;F1058-F1065.
46. +-nucleoside cotransporter (hCNT1). Am. J. Physiol. 272:1997;C707-C714.
47. +-nucleoside cotransporter. J. Biol. Chem. 270:1995;13596-13599.
48. Huang Q.Q., Yao S.Y., Ritzel M.W., Paterson A.R., Cass C.E., Young J.D. Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. J. Biol. Chem. 269:1994;17757-17760.
49. Craig J.E., Zhang Y., Gallagher M.P. Cloning of the nupC gene of Escherichia coli encoding a nucleoside transport system, and identification of an adjacent insertion element, IS 186. Mol. Microbiol. 11:1994;1158-1168.
50. Yao S.Y., Cass C.E., Young J.D. Transport of the antiviral nucleoside analogs 3′-azido-3′-deoxythymidine and 2′,3′-dideoxycytidine by a recombinant nucleoside transporter (rCNT) expressed in Xenopus laevis oocytes. Mol. Pharmacol. 50:1996;388-393.
51. Schaner M.E., Wang J., Zevin S., Gerstin K.M., Giacomini K.M. Transient expression of a purine-selective nucleoside transporter (SPNTint) in a human cell line (HeLa). Pharm. Res. 14:1997;1316-1321.
52. +-dependent nucleoside transporters. Pharm. Res. 14:1997;1524-1532.
53. +-dependent nucleoside transporters. J. Biol. Chem. 272:1997;28845-28848.
54. Pajor A.M., Wright E.M. Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. J. Biol. Chem. 267:1992;3557-3560.
55. +/nucleoside cotransport activity in Xenopus laevis oocytes. Biochem. Biophys. Res. Commun. 225:1996;106-111.
56. Spector R. Thymidine transport and metabolism in choroid plexus: effect of diazepam and thiopental. J. Pharmacol. Exp. Ther. 235:1985;16-19.
57. Spector R. Nucleoside and vitamin homeostasis in the mammalian central nervous system. Ann. New York Acad. Sci. 481:1986;221-230.
58. Spector R. Uridine transport and metabolism in the central nervous system. J. Neurochem. 45:1985;1411-1418.
59. Spector R., Eells J. Deoxynucleoside and vitamin transport into the central nervous system. Fed. Proc. 43:1984;196-200.
60. Spector R., Huntoon S. Specificity and sodium dependence of the active nucleoside transport system in choroid plexus. J. Neurochem. 42:1984;1048-1052.
61. Spector R., Huntoon S. Deoxycytidine transport and metabolism in the central nervous system. J. Neurochem. 41:1983;1131-1136.
62. Spector R. Nucleoside transport in choroid plexus: mechanism and specificity. Arch. Biochem. Biophys. 216:1982;693-703.
63. Spector R., Berlinger W.G. Localization and mechanism of thymidine transport in the central nervous system. J. Neurochem. 39:1982;837-841.
64. Spector R. Thymidine accumulation by choroid plexus in vitro. Arch. Biochem. Biophys. 205:1980;85-93.
65. Spector R. Thymidine transport in the central nervous system. J. Neurochem. 35:1980;1092-1098.
66. Wu X., Hui A.C., Giacomini K.M. Formycin B elimination from the cerebrospinal fluid of the rat. Pharm. Res. 10:1993;611-615.
67. Anderson C.M., Xiong W., Young J.D., Cass C.E., Parkinson F.E. Demonstration of the existence of mRNAs encoding N1/cif and N2/cit sodium/nucleoside cotransporters in rat brain. Brain. Res. Mol. Brain Res. 42:1996;358-361.
68. Takasawa K., Suzuki H., Sugiyama Y. Transport properties of 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine in the rat choroid plexus. Biopharm. Drug Dispos. 18:1997;611-622.
69. Redzic Z.B., Segal M.B., Markovic I.D., Gasic J.M., Vidovic V., Rakic L.M. The characteristics of basolateral nucleoside transport in the perfused sheep choroid plexus and the effect of nitric oxide inhibition on these processes. Brain Res. 767:1997;26-33.
70. Washington C.B., Giacomini K.M., Brett C.M. Nucleoside transport in isolated human and rhesus choroid plexus tissue slices. Pharm. Res. 15:1998;1145-1147.
71. Spector R. Hypoxanthine transport and metabolism in the central nervous system. J. Neurochem. 50:1988;969-978.
72. +-dependent nucleobase transporter with broad substrate selectivity. J. Biol. Chem. 270:1995;22816-22819.
73. Washington C.B., Giacomini K.M. Mechanisms of 5-fluorouracil (5-FU) transport in isolated rabbit choroid plexus tissue slices. Pharm. Res. 13:1996;1276-1278.
74. Thomas S.A., Segal M.B. The passage of azidodeoxythymidine into and within the central nervous system: does it follow the parent compound, thymidine? J. Pharmacol. Exp. Ther. 281:1997;1211-1218.
75. Wu D., Clement J.G., Pardridge W.M. Low blood-brain barrier permeability to azidothymidine (AZT), 3TC, and thymidine in the rat. Brain Res. 791:1998;313-316.
76. Takasawa K., Terasaki T., Suzuki H., Sugiyama Y. In vivo evidence for carrier-mediated efflux transport of 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system. J. Pharmacol. Exp. Ther. 281:1997;369-375.